IL13 and eosinophilic esophagitis: Given the underlying immune-mediated inflammatory nature of EoE, characterized by a type 2 inflammatory response with elevated levels of IL-4, IL-5, and IL-13, various immunomodulatory agents have been investigated as potential treatments [16].